Study of Nivolumab in Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma (DLBCL) That Have Either Failed or Are Not Eligible for Autologous Stem Cell Transplant (CheckMate 139)
Clinical trial NCT02038933 · COMPLETED
Trial details
- NCT number
- NCT02038933
- Sponsor
- Bristol-Myers Squibb
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-03-05
- Primary completion
- 2016-04-08
- Enrollment
- 121
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.